In 1994, it was first reported that mutant Kristen rat sarcoma (KRAS) sequences were detected in plasma circulating tumor DNA (ctDNA) of pancreatic cancer patients by PCR with allele specific primers, which means that liquid biopsy is promising for cancer detection (5). This evidence concerns the gene KRAS and familial pancreatic carcinoma.